Tokyo, Dec. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060080) titled 'Prophylactic use of constipation drugs for prevention of opioidinduced
constipation in patients with opioid starting: a systematic
review and meta-analysis' on Dec. 14.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - IUHW
Condition:
Condition - Patients with opioid starting
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We conducted a systematic review and meta-analysis on the prophylactic use of naldemedine for the prevention of opioid-induced constipation in patients initiating opioid therapy.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with opioid starting
Key exclusion criteria - none
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 14 Day
Anticipated trial start date - 2026 Year 01 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068712
Disclaimer: Curated by HT Syndication.
